Barros Jeison de Nadai, Almeida Simone Ribeiro Araújo de, Lowen Marcia Serva, Cunha Marcelo Carvalho da, Gomes José Álvaro Pereira
Department of Ophthalmology & Visual Sciences, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Department of Pathology, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Arq Bras Oftalmol. 2015 Mar-Apr;78(2):126-32. doi: 10.5935/0004-2749.20150033.
Impression cytology (IC) has been widely used as a method for evaluating the ocular surface and superficial cells layers in the diagnosis and follow-up after treatment of several ocular surface tumors of both epithelial and melanocytic origin. Information regarding this can be found in the English-language literature since 1992. Using either cellulose acetate or Biopore membranes for specimen collection, a high correlation has been found between IC and tissue histology. Compared with exfoliative cytology with spatula, IC is less traumatic to the patient's eye, provides a precise location of the area being studied, and allows accurate observation of the cells the way they exist in vivo. The additional advantage of IC is the preservation of limbal stem cells responsible for continuous corneal epithelium renewal; these can be affected after incisional or excisional biopsy at the corneoscleral limbus, which is the most frequent site of appearance of tumors in the stratified epithelium. Treatment for ocular surface squamous neoplasia has historically included surgery, but nonsurgical interventions have also been adopted. Hence, in certain cases, ophthalmologists may prefer interventions less invasive than surgical biopsy such as of impression cytology for both initial diagnosis and therapeutic monitoring of treatment for ocular surface lesions. Nevertheless, it should be considered that IC may be less helpful if the results conflict with the clinical picture or if the clinical diagnosis is uncertain and results are negative. In such cases, surgical biopsy is required for accurate diagnosis. The purpose of this review is to examine the published literature on the utilization of IC for the diagnosis and management of ocular surface tumors and to discuss the requirement for further investigation on the subject.
印片细胞学检查(IC)已被广泛用作一种评估眼表及浅表细胞层的方法,用于诊断和随访上皮源性和黑素细胞源性的多种眼表肿瘤治疗后情况。自1992年以来,相关信息可在英文文献中找到。使用醋酸纤维素或Biopore膜收集标本时,已发现印片细胞学检查与组织组织学之间具有高度相关性。与用刮匙进行的脱落细胞学检查相比,印片细胞学检查对患者眼睛的创伤较小,能提供所研究区域的精确位置,并能按细胞在体内的存在方式进行准确观察。印片细胞学检查的另一个优点是能保留负责角膜上皮持续更新的角膜缘干细胞;在角膜缘进行切开活检或切除活检后,这些干细胞可能会受到影响,而角膜缘是分层上皮中肿瘤最常出现的部位。眼表鳞状上皮肿瘤的治疗历来包括手术,但也采用了非手术干预措施。因此,在某些情况下,眼科医生可能更倾向于采用比手术活检侵入性小的干预措施,如印片细胞学检查,用于眼表病变的初始诊断和治疗监测。然而,应考虑到,如果结果与临床表现不符,或者临床诊断不确定且结果为阴性,印片细胞学检查可能帮助不大。在这种情况下,需要进行手术活检以获得准确诊断。本综述的目的是研究已发表的关于印片细胞学检查在眼表肿瘤诊断和管理中的应用的文献,并讨论该主题进一步研究的必要性。